These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 387203)

  • 1. A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinoma.
    Woolley PV; MacDonald JS; Smythe T; Haller DG; Hoth DF; Rosenoff S; Schein PS
    Cancer; 1979 Oct; 44(4):1211-4. PubMed ID: 387203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
    MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
    Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
    MacDonald JS; Schein PS; Woolley PV; Smythe T; Ueno W; Hoth D; Smith F; Boiron M; Gisselbrecht C; Brunet R; Lagarde C
    Ann Intern Med; 1980 Oct; 93(4):533-6. PubMed ID: 7436184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer.
    Gisselbrecht C; Smith FP; MacDonald JS; Korsmeyer SJ; Boiron M; Woolley PV; Schein PS
    Cancer; 1983 May; 51(10):1792-4. PubMed ID: 6219735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
    Biran H; Sulkes A; Biran S
    Oncology; 1989; 46(2):83-7. PubMed ID: 2710481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
    Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
    Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
    Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
    Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer.
    Wagener DJ; Yap SH; Wobbes T; Burghouts JT; van Dam FE; Hillen HF; Hoogendoorn GJ; Scheerder H; van der Vegt SG
    Cancer Chemother Pharmacol; 1985; 15(1):86-7. PubMed ID: 4039985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
    Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
    Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lung.
    Butler TP; MacDonald JS; Smith FP; Smith LF; Woolley PV; Schein PS
    Cancer; 1979 Apr; 43(4):1183-8. PubMed ID: 445320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.
    Fraile RJ; Samson MK; Baker LH; Talley RW
    Cancer Treat Rep; 1979; 63(11-12):1983-7. PubMed ID: 230896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM).
    Haim N; Cohen Y; Honigman J; Robinson E
    Cancer Chemother Pharmacol; 1982; 8(3):277-80. PubMed ID: 6897021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.